Mizoribine for the treatment of lupus nephritis in children and adolescents

Clinical Nephrology

Volumn 62, Issue 6, 2004, Pages 412-417

  Tanaka, Hiro ^a   Tsugawa, K ^a   Tsuruga, K ^a   Suzuki, K ^a   Nakahata, T ^a   Ito, E ^a   Waga, S ^b  

^a HIROSAKI UNIVERSITY   (Japan)

^b Namioka   (Japan)

Author keywords

Lupus nephritis; Maintenance therapy; Mizoribine; Pubertal patients; Systemic lupus erythematosus

Indexed keywords

CREATININE; CYCLOPHOSPHAMIDE; DNA ANTIBODY; DOUBLE STRANDED DNA; METHYLPREDNISOLONE; MIZORIBINE; PREDNISOLONE;

ADOLESCENT; AMENORRHEA; ANTIBODY TITER; ARTICLE; BONE MARROW TOXICITY; CLINICAL ARTICLE; COMPLEMENT HEMOLYSIS TEST; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DISEASE CLASSIFICATION; DISEASE SEVERITY; DRUG DOSE REGIMEN; DRUG EFFICACY; DRUG MEGADOSE; DRUG SAFETY; FEMALE; FOLLOW UP; GASTROINTESTINAL SYMPTOM; GONADAL DISEASE; HAIR LOSS; HUMAN; KIDNEY BIOPSY; LEUKOPENIA; LIVER DYSFUNCTION; LUPUS ERYTHEMATOSUS NEPHRITIS; MALE; OPPORTUNISTIC INFECTION; PROTEIN URINE LEVEL; RETROSPECTIVE STUDY; SCHOOL CHILD; SHORT STATURE; STATISTICAL ANALYSIS; STATISTICAL SIGNIFICANCE;

EID: 10644234704     PISSN: 03010430     EISSN: None     Source Type: Journal    
DOI: 10.5414/cnp62412     Document Type: Article

References (23)

1. Aihara Y, Miyamae T, Ito S, Kobayashi S, Imagawa T, Mori M, Ibe M, Mitsuda T, Yokota S 2002 Mizoribine as an effective combined maintenance therapy with prednisolone in childhood-onset systemic lupus erythematosus. Pediatr Int 44: 199-204
2. Al Salloum AA 2003 Cyclophosphamide therapy for lupus nephritis: poor renal survival in Arab children. Pediatr Nephrol 18 357-361
3. Austin HA, Balow JE 1999 Natural history and treatment of lupus nephritis. Semin Nephrol 19: 2-11
4. Chan TM, Li FK, Tang CSO, Wong RWS, Fang GX, Ji YL, Lau CS, Wong AKM, Tong MKL, Chan KW, Lai KN 2000 Efficacy of mycophenolate mofetil in patients with diffuse proliferative lupus nephritis. N Engl J Med 343: 1156-1162
5. Hamasaki T, Mori M, Kinoshita Y, Saeki T, Sakano T 1997 Mizoribine in steroid-dependent nephrotic syndrome of childhood. Pediatr Nephrol 11: 625-627
6. Honda M 2002 Nephrotic syndrome and mizoribine in children. Pediatr Int 44: 210-216
7. Kamata K, Okubo M, Uchiyama T, Masaki Y, Kobayashi Y, Tanaka T 1984 Effect of mizoribine on lupus nephropathy of New Zealand black/white F1 hybrid mice. Clin Immunol Immunopathol 33: 31-38
8. Kaneko K, Nagaoka R, Ohtomo Y, Yamashiro Y 1999 Mizoribine for childhood IgA nephropathy. Nephron 83: 376-377
9. Kawasaki Y, Suzuki J, Sakai N, Etoh S, Murai H, Nozawa R, Suzuki H 2004 Efficacy of prednisolone and mizoribine therapy for diffuse IgA nephropathy. Am J Nephrol 24: 147-153
10. Mok CC, Lai KN 2002 Mycophenolate mofetil in lupus glomerulonephritis. Am J Kidney Dis 40: 447-557
11. Nagaoka R, Kaneko K, Ohtomo Y, Yamashiro Y 2002 Mizoribine treatment for childhood IgA nephropathy. Pediatr Int 44: 217-223
12. Niaudet P 2000 Treatment of lupus nephritis in children. Pediatr Nephrol 14: 158-166
13. Shibasaki T, Matsuyama H, Gomi H, Usui M, Ishimoto F, Sakai O 1996 Mizoribine reduces urinary protein excretion in rats given puromycin aminonucleoside. Am J Nephrol 16: 167-172
14. Sonda K, Takahashi K, Tanabe K, Fuchinoue S, Hayasaka Y, Kawaguchi H, Teraoka S, Toma H, Ota K 1996 Clinical pharmacokinetic study of mizoribine in renal transplantation patients. Transplant Proc 28: 3643-3648
15. Takahashi S, Wakui H, Gustafsson JA, Zilliacus J, Itoh H 2000 Functional interaction of the immunosuppressant mizoribine with the 14-3-3 protein. Biochem Biophys Res Commun 274: 87-92
16. Tanaka H, Nakahata T, Tsugawa K, Tsuruga K, Yumura W, Ito E 2004 Mizoribine pulse therapy for patients with flares of lupus nephritis: a one-year observation. Clin Nephrol 62: 165-166
17. Tanaka H, Suzuki K, Nakahata T, Sato T, Ito E 2003a Mizoribine oral pulse therapy for a patient with severe lupus nephritis. Pediatr Int 45: 488-490
18. Tanaka H, Suzuki K, Nakahata T, Tsugawa K, Ito E, Waga S 2003b Mizoribine oral pulse therapy for patients with disease flare of lupus nephritis. Clin Nephrol 60: 390-394
19. Tanaka H, Tateyama T, Waga S 2001 Methylprednisolone pulse therapy in Japanese children with severe lupus nephritis. Pediatr Nephrol 16: 817-819
20. Yang LY, Chen WP, Lin CY 1994 Lupus nephritis in children. A review of 167 patients. Pediatrics 94: 335-340
21. Yokota S 2002 Mizoribine: Mode of action and effects in clinical use, Pediatr Int 44: 196-198
22. Yoshioka K, Ohashi Y, Sakai T, Ito H, Yoshikawa N, Nakamura H, Tanizawa T, Wada H, Maki S 2000 A multicenter trial of mizoribine compared with placebo in children with frequently relapsing nephrotic: syndrome. Kidney Int 58: 317-324
23. Yumura W, Uchida K, Kawashima A, Kobayashi H, Miwa N, Honda K, Nitta K, Nihei H 1999 Evaluation of plasma concentration of mizoribine as an immunosuppressive agent in lupus nephritis patients (in Japanese). Jin to Toseki (Kidney Dial Tokyo) 47: 705-708